joimax® Announces Partnership with Southeast Asia Distributor, Transmedic Group

Karlsruhe (GER) – joimax®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is pleased to announce a new partnership with Transmedic Group, a top medical device distributor headquartered in Singapore. In this exclusive deal, Transmedic will represent joimax® in Singapore, Hong Kong, Philippines and Indonesia.

The long-term partnership will provide a broader surgical choice for patients considering endoscopic minimally invasive spinal surgery in these markets. With recent advances in the field of endoscopic discectomy (ED), the procedure has potential to supersedemicrodiscectomy (MD) as the gold standard of care in management of lumbar disc disease, as the latest literature suggests.

“joimax® is very much looking forward to working with Transmedic Group,” says joimax® Founder and CEO Wolfgang Ries. “With the rising popularity of endoscopic approaches in the management of spinal diseases, we’re able to deliver the highest standard of patient care, strengthen our sales activities, and enter into another important partnership across APAC.” 

Teo Kee Meng, managing director of Transmedic Group commented, “We’re very pleased to partner with joimax®. With their technological advancements and use of new spinal access corridors, a major prevention of spinal structure collateral damage is assured, allowing for significantly reduced complications and improved postoperative recovery times.”

About Transmedic Group
Transmedic Group was founded in 1980 with the aim of becoming the top specialist in the advanced medical technology area in Southeast Asia. Headquartered in Singapore, the privately held company has since grown its presence in seven countries with more than 500 employees, and is well-renowned as the leading provider of latest technologies in healthcare.

joimax® Expands Presence in Australia

Karlsruhe (GER) – joimax®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is pleased to announce a new partnership with Australian medical device distributor, LifeHealthcare. The two companies have entered into a long-term relationship to provide a broader surgical choice for patients considering spinal surgery.

“We’re looking forward to working with a partner as strong as LifeHealthcare,” says joimax® Founder and CEO Wolfgang Ries. “LifeHealthcare shares our goals and vision, ensuring that we are able to deliver the highest standards of patient care.”

Endoscopic spine surgery has been steadily growing in popularity since the late 1990’s with exponential growth in the technique for the past ten years. Surgeons throughout the world have reported that this type of surgery can assist patients in faster recovery, enabling them to reduce their post-operative stay.

“We’re very pleased to collaborate with joimax®,” comments LifeHealthcare Chief Executive Officer Matt Muscio. “Endoscopic spine surgery is a technique that enables patients to have access to truly minimally invasive surgical procedures of the spine.”

Thus, joimax® strengthens its sales activities in Australia and enters into another important partnership across APAC.

About LifeHealthcare

LifeHealthcare is a leading independent provider of healthcare solutions in Australia and New Zealand bringing healthcare professionals innovative medical devices by partnering with world class companies who share the vision of innovation and making a real difference to people’s lives. LifeHealthcare has been recognised as one of the Financial Times 1,000 High Growth Companies in Asia-Pacific. In May 2018, LifeHealthcare was acquired by Australia’s largest private equity fund, Pacific Equity Partners, a market leader that has been recognised as a Top 20 Consistent Performer Globally by Prequin. For further information, please visit www.lifehealthcare.com.au.

joimax® Launches New iLESSYS® Biportal Interlaminar Endoscopic Surgical System

KARLSRUHE, Germany–(BUSINESS WIRE)–joimax®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, launched its new iLESSYS® Biportal Interlaminar Endoscopic Surgical System for the treatment of spinal disorders at the EUROSPINE 2023 Annual Meeting in Frankfurt and at the SMISS Annual Forum (Society for Minimally Invasive Spine Surgery) in Las Vegas, marking its global debut. This week, it will be presented at the NASS meeting (North American Spine Society) in Los Angeles.

 

The new instrument set, iLESSYS® Biportal for unilateral biportal endoscopy (UBE), expands the wide range of joimax® endoscopic offerings by separating the instrument working port from the endoscope, allowing for free relative movement between the two. The iLESSYS® Biportal offers all instruments tailor-made for biportal spinal endoscopy, with:

  • A special Triangulation Tool to simplify the access triangulation of two ports
  • Biportal specific working tubes with inbuilt irrigation outflow control for precise water management
  • Larger, more powerful tools for effective tissue ablation and resection

“This system is excellent and will allow me to perform the surgeries not only biportally but also bimanually,” stated Javier Quillo-Olvera, M.D., spinal neurosurgeon and an expert in biportal surgery at the Brain and Spine Care Group, Querétaro, Mexico. “It allows me to use the iLESSYS® Pro working channel endoscope. I’m excited to use it with my patients.”

EUROSPINE attendees were impressed that this comprehensive system could be used as a biportal system and available for bimanual surgical procedures. Moreover, the iLESSYS® played a key role during the expert talks, spurring debate about when to use the transforaminal (TESSYS®) and when to use the interlaminar (iLESSYS®) approach for a given spinal disease.

“The system will be part of the ESPINEA® training and education program and will be fully implemented in the workshop courses by the end of the year,” commented Wolfgang Ries, CEO and founder of the joimax® group. “We´ve already lined up a range of surgical faculty in Europe (Dr. Ralf Wagner, Dr. Maxime Challali, Dr. Raed Abohussein, Dr. Miguel Loureiro), in the Americas (Dr. Peter Derman, Dr. Meng Huang, Dr. Javier Quillo-Olvera) and in Asia (Prof. Si-Young Park, Dr. Junseok Bae) among others in each of these regions, with many more to follow.”

 

 

Veröffentlicht in AllgemeinVerschlagwortet mit

joimax® Signs National Distribution Partner in Taiwan

(Karlsruhe-GER, 26 June 2020)
Karlsruhe (GER) – joimax®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is pleased to announce a new countrywide distributor in Taiwan, Hi-Clearance Inc. With the aim of building an effective, long-term relationship, the strategic supplier partnership is a further milestone in the international growth of joimax® .

“Hi-Clearance is our ideal sales and service partner,” says joimax® CEO and Founder Mr. Wolfgang Ries. With their streamlined structure and process in place, we are confident joimax® will penetrate this new market very successfully”.

Hi-Clearance Inc. has over 239 employees, and is a well-known supplier of medical materials and equipment in Taiwan. “We are very pleased about the new strategic partnership and are excited to continue the strong growth of both companies,” states Hi-Clearance Chairman Mr. John Lee and President Mr. Ernie Chen. “We are dedicated to establishing joimax® as the leading brand of endoscopic spine surgery in Taiwan.”

Hi-Clearance Inc. is headquartered in Taipei with four other branches spread across the country. The main business includes products for Hemodialysis, Critical Care, Dental, Cardiology, Homecare Devices, Nutrition and a major Spine Surgery Division. In 2019, sales were USD 107 million.

Endoscopic Spine Activities Peak During Summer 2023, joimax® Continues to Lead the Way

KARLSRUHE, Germany–(BUSINESS WIRE)–joimax®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, presented at the ESPINEA® World Summit at the prestigious Royal College of Surgeons of Edinburgh, PASMISS in Taiwan, NASSi in Bangkok, the ASEAN MISST in Jakarta, and at the first Annual Endoscopic Spine Surgery Symposium at the Seattle Science Foundation.

 

 

From July 13 to 15 more than 80 attendees from 22 countries connected at the ESPINEA® World Summit. “This historic event was a major milestone in the educational training activity of ESPINEA®, where we are proud to guide highly active surgeons from around the world within this encouraging field of endoscopic spinal therapy,” concluded ESPINEA® board members Dr. Alastair Gibson and Dr. Menno Iprenburg.

The July events provided joimax® the ideal opportunity to launch the highly anticipated surgical access systems, iLESSYS® Biportal and TESSYS® Trans SAP, along with the new electrosurgical probe, Vaporace® Bipo, which are key to the soon-to-be announced endoscopic expandable fusion platform.

joimax® will also share its latest developments at EUROSPINE in Frankfurt, affording participants an opportunity to attend an open house at their global headquarters in Karlsruhe, where they will further learn about joimax®’s research and manufacturing capabilities. Moreover, the joimax® US team will welcome NASS attendees in its hometown of Los Angeles.

“We are excited to see the widespread acceptance of endoscopic spine surgery around the globe,” said joimax® Founder and CEO Wolfgang Ries. “Having reached a tipping point, the NASS endoscopic “Surgical Stadium” event, will be another highlight the spine community can look forward to”. For further information and event registration, contact joimax®.

 

Veröffentlicht in AllgemeinVerschlagwortet mit

New partnership: joimax® joins forces with JAPAN MEDICALNEXT CO., LTD.

(Karlsruhe-GER, 16 June 2020)

Karlsruhe (GER) – joimax®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is starting as of now a new partnership in Japan. The distributor JMC- JAPAN MEDICALNEXT CO., LTD. and joimax® are pursuing a long-term sales cooperation that will result in an extensive distribution agreement for the entire Japanese market.

“joimax® is looking forward to working with a partner strong as JMC, says joimax® Founder and CEO Wolfgang Ries and adds, “a company that has the necessary personnel, expertise, as well as the corresponding specialization and penetration of the market”. Masayuki Yoshimura, President and CEO of JMC, explains, “We are very excited to partner with joimax®. With our shared vision for advancing the field of minimum invasive spinal surgery, we are looking forward to introducing the globally recognized joimax® products in Japan”. Thus, joimax® strengthens its sales activities in Japan and enters into another important partnership in Asia.

JAPAN MEDICALNEXT CO., LTD. founded in 1992 is located in Osaka, Japan. With 314 employees at its locations and an Orthopedics Division that will focus on joimax® products, the company is a wholly-owned entity of MC Healthcare, Inc. (subsidiary of Mitsubishi Corporation) and prominent supplier of medical devices in Japan.

joimax® demonstrating its innovative minimally invasive endoscopic spine surgery solutions at Global Spine Congress 2023

joimax® demonstrating its innovative minimally invasive endoscopic spine surgery solutions at Global Spine Congress 2023

Prague, Czech Republic | June 2023 – During this years Global Spine Congress (GSC) joimax® CEO & Founder, Wolfgang Ries, talked to the GSC Chairman, Jeffery Wang, MD, PhD about the latest innovations by joimax®.

Click the link below to see the full interview! 

https://youtu.be/vTiTHGuHFCs

joimax® Organizes its First Online Endoscopic Spine Symposium

Karlsruhe (GER) — joimax®, the Germany-based market leader of technologies and training methods for full-endoscopic minimally-invasive spinal surgery, held its first online global symposium, “Endoscopic Spine Surgery – Indications, Technology and Limitations”, at its headquarters in the Training and Education Center (TEC) in Karlsruhe-Germany, on April 24-25, 2020.

In view of the coronavirus restrictions introduced by many governments, in March,  joimax® began holding weekly webinars, in partnership with key surgeons, to demonstrate the latest endoscopic techniques. The training sessions culminated with a two-day Symposium, full of live discussions and video demonstrations, scheduled during Western and Eastern time zones.

On April 24, joimax® Founder and CEO Wolfgang Ries, moderated a panel with faculty members Ralf Wagner, MD (Ligamenta Spine Center Frankfurt-Germany) and Christoph Hofstetter, MD, PhD (University of Washington Medicine, Neurosurgery Department, Seattle/USA). The following day, faculty member, Junseok Bae, MD (President of Wooridul Spine Hospital Seoul, South Korea), joined the panel.

On both days, the agenda included a theoretical part focused on transforaminal and interlaminar indications, and the general possibilities of endoscopy from lumbar to thoracic to cervical, as well as a hands-on lab portion. In the wet lab, Dr. Ralf Wagner demonstrated the joimax® product application of TESSYS® and iLESSYS® in specific indications. Moreover, there were presentations of Intracs® em , the first electromagnetic system for endoscopic spine applications that can navigate instruments directly at the tip. This navigation system combines lateral and AP images of the C-arm with CT scan, providing surgeons with most accurate views of the target region.

The Symposium also featured special guests: Dr. Menno Iprenburg (Iprenburg Spine Clinic, Veenhuizen, Netherlands) and Prof. Alastair Gibson (The Royal Infirmary of Edinburgh, Edinburgh Scotland); both board members of ESPINEA® Academy, who gave their valued input, based on their long-lasting experience.

“This is the  future of digital education and a great way to virtually meet and learn,” stated Dr. Iprenburg.  Prof. Gibson added, “excellent Symposium; it couldn’t get any better”.

The Symposium marked a major milestone, with 430 participants. Surgeons from all over the world joined this unique online education program and stimulating Q&A session.

When safe, joimax® will transition back to on-site workshops and trainings, but in the  meantimewill continue with its attention-grabbing online webinars.

joimax® Updates ESPINEA® Training Facility

KARLSRUHE, Germany – (BUSINESS WIRE) – The newly renovated and expanded Endoscopic Spinal Academy (ESPINEA®) facilities, sponsored by joimax®, makes exceptionally, high-quality training accessible in an innovative and appealing environment. Every day, the Academy offers educational and hands-on workshops to surgery teams, customers and partners.

Ries took on the newly created role of Executive Vice President, Business Development and Operations at joimax®. In this position, based in Germany, he will be responsible for scaling global operations to ensure joimax® continues its exponential growth. Formerly the General Manager, for the past six of his 13-year tenure with joimax®, Ries built out the United States and Latin American markets. 


“We are continuously developing and adapting our programs to meet customer demand”.


Courses and workshops at a pre-clinical and clinical levels

For almost five years, ESPINEA®, which is accredited by the Royal College of Surgeons of Edinburgh, has stood for excellence in training in the field of endoscopic spinal surgery. After the recent inauguration of ESPINEA® China, joimax® has refurbished and enlarged the existing Karlsruhe training facilities into a modern, state-of-the art center to support their growing educational and training programs. The showroom demonstrates solutions from joimax®, the market leader in endoscopic spinal surgery technologies, enabling visitors to experience this mastery daily.

Organized in sections, by product line, practitioners can try out each clinical model, simulating an operative environment, and learn firsthand about the positive ergonomics and streamlined workflow of these offerings. All labs are equipped with integrated joimax® surgery systems, including the latest generation endoscopic tower, NAVENTO®. The surgery stations are digitally connected to imaging and to the joimax® Intracs® electromagnetic navigation system so that the endoscopic spinal surgery methods and applications can be reproduced during training. Moreover, the furnishings have been fully optimized so that the rooms can be easily adapted to new products and solutions.

“As a leading innovator in spinal surgery techniques, it’s important that ESPINEA® offers a pioneering center to further education and training,” said Wolfgang Ries, CEO and founder of joimax® and chairman and founder of ESPINEA®. “The dynamic, holistic and needs-oriented program sets new standards.”

The main focus is on endoscopic spinal care solutions for pain therapy, decompression, deherniation, and spinal stabilization. All hands-on sections have an open lab design, and bring the concept to life on how the products work together.

Setting standards in training of endoscopic spinal surgery

Professional knowledge and well-practiced skills are the building blocks for successful endoscopic spinal surgery.

“We are continuously developing and adapting our programs to meet customer demand,” said Susanne Schmidinger, senior director, global marketing and education. “We are convinced that our holistic and target-oriented education puts surgery teams in the position to optimally implement our available technologies and solutions for their patients.“

At the facility, an experienced, dedicated global team of certified faculty share their expertise and know-how. Every trainee is individually accompanied along the entire learning journey.

“It’s important that surgeons be able to directly and efficiently apply joimax® systems and methods in their daily work,” said Ries. “That’s why we developed the ESPINEA® 3-step education program of visitation, hands-on workshop, and simulated live surgery.”

The program is available at ESPINEA® USA, Asia, China, and Europe.

 

joimax® starts the official sale of its EndoLIF® Delta and DoubleWedge cages. All three members of EndoLIF® family CE approved.

Karlsruhe, GER– July 15, 2019 –joimax®, the Germany-based market leader of technologies and training methods for full-endoscopic minimally-invasive spinal surgery, announces the official sales launch of its complete EndoLIF® family. EndoLIF® is an instrument set for endoscopic-assisted minimally invasive lumbar interbody fusion. As already announced and showcased at earlier events, the EndoLIF® product line consists of three members now: the well-known EndoLIF® O/On-Cage, the EndoLIF® Delta Cage, and the latest EndoLIF® Double Wedge Cage. The complete EndoLIF® product family is now CE-approved and fully available. Moreover, the EndoLIF® O/On-Cage is FDA-approved.

All EndoLIF® Implants are manufactured using a 3D printing process, which ensures an open diamond cell structure. The cages are safely implanted via the guide wire and are fillable with bone or bone substitute material. With their rough and porous surface, the implants guarantee optimal bone ingrowth, stability and finally fusion.

The EndoLIF® Cage family provides the right implant for every patient and is the perfect solution for endoscopic spinal fusion. With the gentle and atraumatic access via gradual tissue dilatation, muscles remain intact leaving important biomechanical structures in place after surgery.

Like with any endoscopic procedure compared to open surgery, all advantages for fusion are now given with the EndoLIF® program also. With one EndoLIF® Instrument Set all three cages of the EndoLIF® family can be implemented.

Dr. Florian Zentz, (Munich, GER) emphasizes “the extraordinarily high primary stability of the EndoLIF® DoubleWedge-Cage”. He continues enthusiastically: “After insertion the cage sits very firmly in the intervertebral disc space and adjusts the angulation up to 18 degrees, almost directly enabling an optimal lordosis correction.”

Dr. Ralf Wagner, (Frankfurt, GER) is also convinced of the obvious advantages: “The Delta Cage is ideal for the posterior lumbar interbody fusion (PLIF) offering a gentle posterior alternative, especially at level L5-S1 with its large interlaminar window.